1. Cai, Zhen, Moten, Asad, Peng, Danni, Li, Hong-Yu, Lin, Hui-Kuan. 2020. The Skp2 Pathway: A Critical Target for Cancer Therapy. In Seminars in cancer biology, 67, 16-33. doi:10.1016/j.semcancer.2020.01.013. https://pubmed.ncbi.nlm.nih.gov/32014608/
2. Hodeib, Hossam, Abd El Hai, Dina, Tawfik, Mohamed A, Mansour, Wael, Youssef, Amira. 2022. The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia. In Genes, 13, . doi:10.3390/genes13060948. https://pubmed.ncbi.nlm.nih.gov/35741710/
3. Fong, Lon W R, Lee, Jangsoon, Lin, Hui-Kuan, Ueno, Naoto T, Zhang, Shuxing. 2022. A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer. In Scientific reports, 12, 2478. doi:10.1038/s41598-022-06451-w. https://pubmed.ncbi.nlm.nih.gov/35169199/
4. Liu, Xia, Sun, Changfa, Zou, Kexin, Yu, Chuanjin, Huang, Hefeng. 2020. Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction. In EBioMedicine, 61, 103058. doi:10.1016/j.ebiom.2020.103058. https://pubmed.ncbi.nlm.nih.gov/33096483/
5. Wu, Ting, Gu, Xinsheng, Cui, Hongmei. 2021. Emerging Roles of SKP2 in Cancer Drug Resistance. In Cells, 10, . doi:10.3390/cells10051147. https://pubmed.ncbi.nlm.nih.gov/34068643/
6. Sakaue-Sawano, Asako, Yo, Masahiro, Komatsu, Naoki, Miyoshi, Hiroyuki, Miyawaki, Atsushi. 2017. Genetically Encoded Tools for Optical Dissection of the Mammalian Cell Cycle. In Molecular cell, 68, 626-640.e5. doi:10.1016/j.molcel.2017.10.001. https://pubmed.ncbi.nlm.nih.gov/29107535/
7. Wang, Shuo, Raven, Jennifer F, Koromilas, Antonis E. 2010. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells. In Molecular cancer research : MCR, 8, 798-805. doi:10.1158/1541-7786.MCR-10-0027. https://pubmed.ncbi.nlm.nih.gov/20407011/
8. Zhu, Chang Qi, Blackhall, Fiona H, Pintilie, Melania, Shepherd, Frances A, Tsao, Ming-Sound. . Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker. In Clinical cancer research : an official journal of the American Association for Cancer Research, 10, 1984-91. doi:. https://pubmed.ncbi.nlm.nih.gov/15041716/
智鼠故事 
